2019年6月科睿唯安发布的期刊引证报告中，SAGE期刊呈现了良好的增长趋势。
今天，我们来看看这本SCI期刊：
Therapeutic Advances in Neurological Disorders
。
Therapeutic Advances in Neurological Disorders
是经过同行评审的开放获取期刊，
出版神经病学相关领域的前沿探索和创新研究
。
该刊最新影响因子(JCR2018)为
3.580
。
Therapeutic Advances in Neurological Disorders (TAND)
is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of neurology.
Therapeutic Advances in Neurological Disorders
delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of neurological conditions. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in neurology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The editors welcome original research articles across all areas of neurology.
The journal publishes original research articles and review articles primarily. Original research manuscripts may include
laboratory, animal or human/clinical studies – all phases
. Letters to the Editor and
Case Reports will also be considered
.
Authors will enjoy:
-
Authors will enjoy：
-
-
Listed in PubMed, SCIE, Scopus and DOAJ
-
International expert Editorial Board and panel of Associate Editors
-
Rigorous and fast peer review
-
Average time from submission to first decision is 36 days
-
-
期刊主页：
-
https://journals.sagepub.com/home/tan
长按扫描上方二维码
访问
TAN
期刊首页，了解更多详情
近三年来，
Therapeutic Advances in Neurological Disorders
的影响因子
一直都在三四分
。
即
时影响因子计算发现，
2019年9月17日，2.835
。
按照往年经验
，在2020年6月份公布的IF中，它将不低于
4分(或许有机会冲击5分)
！
但因为距离明年6月份时间还很长，因此具体IF分值，年底的预测会准确一些！
有4
+分以上发表要求的
，来看看这个
SCI期刊
吧！
